GLP-1 therapies are reshaping metabolic care at unprecedented speed — but alongside the headlines, clinicians are left navigating complex questions around long-term outcomes, sustainability, nutrition and patient dependency.
This thought-leadership evening brings healthcare professionals together to explore how GLP-1s fit into modern metabolic care — without losing sight of physiology, behaviour and long-term health.
Nutrition Collective are delighted to welcome Dr David Unwin as the keynote speaker. A GP, internationally recognised educator, and one of the most trusted clinical voices in metabolic health. Known for his measured, evidence-led approach, Dr Unwin will explore how GLP-1 therapies can be used thoughtfully and responsibly, alongside nutrition-first strategies that protect metabolic resilience, muscle mass, and patient autonomy.
Rather than positioning GLP-1s as a silver bullet — or dismissing them outright — this keynote will challenge clinicians to think critically, ethically and systemically about where these therapies belong in practice.
Click here for more information and to register
Tags: cpd